HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

metuximab

(131)I-labeled HAb18G/CD147-specific monoclonal antibody Fab'2 fragment for treatment of hepatocellular carcinoma
Also Known As:
(131I)-metuximab; Licartin
Networked: 12 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Feng, Qiang: 5 articles (06/2009 - 03/2006)
2. Xu, Jing: 4 articles (09/2014 - 06/2006)
3. Chen, Zhi-Nan: 4 articles (09/2014 - 06/2006)
4. Mi, Li: 4 articles (06/2007 - 03/2006)
5. Zhu, Ping: 4 articles (06/2007 - 03/2006)
6. Tian, Rong: 4 articles (06/2007 - 03/2006)
7. Zhang, Yang: 3 articles (09/2014 - 03/2006)
8. Li, Yu: 3 articles (06/2009 - 06/2006)
9. Zhang, Qing: 3 articles (06/2007 - 06/2006)
10. Song, Fei: 3 articles (06/2007 - 06/2006)

Related Diseases

1. Hepatocellular Carcinoma (Hepatoma)
2. Neoplasm Metastasis (Metastasis)
3. Liver Neoplasms (Liver Cancer)
4. Neoplasms (Cancer)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Immunoconjugates (Immunoconjugate)
2. Antigens
3. Iodine
4. metuximab
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Matrix Metalloproteinases
7. Antibodies

Related Therapies and Procedures

1. Radioimmunotherapy
2. Liver Transplantation